Cocrystal’s COVID-19 antivirals; plus a portable breast cancer diagnostic, Tarveda mini-drug conjugate for solid tumors, and more

BioCentury’s roundup of preclinical news

Broad-spectrum coronavirus protease inhibitors
A Wichita State University, University of Iowa and Kansas State University team reported in a Science Translational Medicine article the generation of a series of inhibitors of the protease 3CLpro from MERS-CoV, SARS-CoV and SARS-CoV-2. One of the compounds

Read the full 428 word article

How to gain access

Continue reading with a
two-week free trial.